Treatment of Urinary Tract Infection During First Trimester of Pregnancy
For uncomplicated UTIs during the first trimester of pregnancy, nitrofurantoin 50-100mg four times daily for 5-7 days is the recommended first-line treatment, with fosfomycin 3g single dose as an appropriate alternative. 1
Diagnostic Confirmation
Before initiating treatment, proper diagnosis is essential:
- Obtain a clean-catch midstream urine specimen for culture and sensitivity testing
- Confirm diagnosis with positive urine culture (≥50,000 CFUs/mL of a single urinary pathogen) 2
- Screening for asymptomatic bacteriuria should be performed at least once in early pregnancy 2
Treatment Algorithm
First-line options:
Nitrofurantoin 50-100mg four times daily for 5-7 days
Fosfomycin 3g single dose
- Comparable efficacy to nitrofurantoin 4
- Single-dose administration reduces exposure
- Good option when compliance might be an issue
Second-line options (based on culture sensitivity):
- Cephalexin 50-100 mg/kg per day in 4 doses 2
- Amoxicillin-clavulanate 20-40 mg/kg per day in 3 doses 2
Avoid during pregnancy:
- Fluoroquinolones (contraindicated)
- Trimethoprim-sulfamethoxazole in first trimester (potential teratogenic risk)
- Tetracyclines (contraindicated throughout pregnancy)
Special Considerations
Severity assessment:
- For mild-moderate symptoms: oral therapy is appropriate
- For severe symptoms (high fever, flank pain, vomiting): consider hospitalization and parenteral therapy with:
- Ceftriaxone 75 mg/kg every 24h
- Cefotaxime 150 mg/kg per day divided every 6-8h 2
Treatment duration:
- 5-7 days for uncomplicated cystitis
- 7-14 days for pyelonephritis 1
- Shorter courses (1-3 days) are inferior and should be avoided 2
Follow-up
- Obtain a test-of-cure urine culture 1-2 weeks after completing treatment
- Screen periodically throughout pregnancy as recurrence risk is high
- Consider renal and bladder ultrasonography if symptoms persist or recur 2
Important Caveats
First trimester considerations: While there have been some concerns about nitrofurantoin and sulfonamides in the first trimester, pregnant women should not be denied appropriate treatment as untreated infections can lead to serious maternal and fetal complications 5
Antimicrobial resistance: Consider local resistance patterns when selecting empiric therapy. Recent studies show high resistance to ampicillin, amoxicillin, and amoxicillin/clavulanic acid among common uropathogens in pregnancy 6
Asymptomatic bacteriuria: Should be treated in pregnancy as it's associated with increased risk of pyelonephritis, preterm birth, and low birth weight 7
Recurrent UTIs: For women with recurrent UTIs during pregnancy, prophylactic strategies may be considered after completing initial treatment, though evidence is limited 7
Untreated UTIs: Can progress to pyelonephritis in up to 20-40% of pregnant women if left untreated, with increased risk of preterm labor and low birth weight 2
By following this evidence-based approach to treating UTIs during the first trimester, clinicians can effectively manage infections while minimizing risks to both mother and fetus.